论文部分内容阅读
乳腺癌是女性最常见的恶性肿瘤之一,其发病率占全身各种恶性肿瘤的7%~10%[1],乳腺癌现已成为当前医学界所关注的重大公共卫生问题[2]。40~60岁之间的绝经期前后的女性是乳腺癌的高发人群,而该年龄的女性通常合并一些慢性病,乳腺癌患者的围术期及术后化疗期均存在一些特点[3],临床药师应当依据乳腺癌患者的个体状况、基础指标、药物治疗方案等为患者制定个体化药学监护模式,监护患者用药情况,
Breast cancer is one of the most common malignant tumors in women. The incidence of breast cancer accounts for 7% -10% of all malignant tumors in the body [1]. Breast cancer has now become a major public health issue that is of concern to the current medical community [2]. Pre-menopausal women between the ages of 40 and 60 are high-risk groups of breast cancer, and women of this age are usually associated with some chronic diseases. Perioperative and postoperative chemotherapy in breast cancer patients have some characteristics [3], clinical Pharmacists should be based on the individual status of breast cancer patients, basic indicators, drug treatment programs for patients to develop personalized pharmacy monitoring mode, monitoring patient medication,